Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymic epithelial tumor × Radiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 25 Rectal Neoplasms 18 Prostatic Neoplasms 18 Glioblastoma 18 Breast Neoplasms 17 Pancreatic Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Lung Neoplasms 14 Head and Neck Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 10 Neoplasm Metastasis 10 Esophageal Squamous Cell Carcinoma 9 Oropharyngeal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Uterine Cervical Neoplasms 7 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Carcinoma, Squamous Cell 6 Urinary Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Gliosarcoma 5 Colorectal Neoplasms 5 Xerostomia 4 Sarcoma 4 Melanoma 4 Glioma 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Anus Neoplasms 4

Interventions

toripalimab 1 pembrolizumab 1 apatinib 1 TP protocol 1 Radiation 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03858582 2021-03-22

neoadjuvant_thymic Epithelial Tumor

Samsung Medical Center

Phase 2 Unknown

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡